Growing community of inventors

Brooklyn, NY, United States of America

Felix Kopp

Average Co-Inventor Count = 4.61

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Felix KoppEvripidis Gavathiotis (3 patents)Felix KoppUlrich G Steidl (2 patents)Felix KoppDenis E Reyna (2 patents)Felix KoppSandhya Kortagere (1 patent)Felix KoppSridhar Mani (1 patent)Felix KoppRichard N Kitsis (1 patent)Felix KoppDulguun Amgalan (1 patent)Felix KoppLorrie Kirshenbaum (1 patent)Felix KoppThomas P Garner (1 patent)Felix KoppChamini Karunaratne (1 patent)Felix KoppZdenek Dvorak (1 patent)Felix KoppFelix Kopp (4 patents)Evripidis GavathiotisEvripidis Gavathiotis (17 patents)Ulrich G SteidlUlrich G Steidl (7 patents)Denis E ReynaDenis E Reyna (2 patents)Sandhya KortagereSandhya Kortagere (16 patents)Sridhar ManiSridhar Mani (8 patents)Richard N KitsisRichard N Kitsis (2 patents)Dulguun AmgalanDulguun Amgalan (1 patent)Lorrie KirshenbaumLorrie Kirshenbaum (1 patent)Thomas P GarnerThomas P Garner (1 patent)Chamini KarunaratneChamini Karunaratne (1 patent)Zdenek DvorakZdenek Dvorak (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Albert Einstein College of Medicine (4 from 504 patents)

2. Drexel University (1 from 654 patents)

3. University of Manitoba (1 from 199 patents)

4. Palacky University Olomouc (1 from 4 patents)


4 patents:

1. 12016845 - BAX activators and uses thereof in cancer therapy

2. 11938128 - Small molecule BAX inhibitors and uses thereof

3. 11724998 - PXR agonists and uses thereof for gut barrier dysfunction treatment and prevention

4. 11382898 - BAX activators and uses thereof in cancer therapy

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…